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ABSTRACT
Background and Objectives: Patients with renal dysfunction (RD) experience worse prognosis after myocardial infarction 
(MI). The aim of the present study was to investigate the impact of admission estimated glomerular filtration rate (eGFR) on 
clinical outcomes of patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation MI 
(STEMI). Subjects and Methods: We retrospectively evaluated 4,542 eligible patients from the Korea Acute Myocardial 
Infarction Registry (KAMIR). Patients were divided into three groups according to eGFR (mL/min/1.73 m
2): normal renal 
function (RF) group (eGFR ≥60, n=3,515), moderate RD group (eGFR between 30 to 59, n=894) and severe RD group (eGFR 
<30, n=133). Baseline characteristics, angiographic and procedural results, and in-hospital outcomes between the three groups 
were compared. Results: Age, gender, Killip class ≥3, hypertension, diabetes, congestive heart failure, peak creatine kinase-MB, 
high sensitivity C-reactive protein, B-type natriuretic peptide, left ventricle ejection fraction, multivessel disease, infarct-relat-
ed artery and rate of successful PCI were significantly different between the 3 groups (p<0.05). With decline in RF, in-hospital 
complications developed with an increasing frequency (14.1% vs. 31.8% vs. 45.5%, p<0.0001). In-hospital mortality rate was 
significantly higher in the moderate and severe RD groups as compared to the normal RF group (2.3% vs. 13.9% vs. 25.6%, 
p<0.0001). Using multivariate logistic regression analysis, adjusted odds ratio for in-hospital mortality was 2.67 {95% confi-
dence interval (CI) 1.44-4.93, p=0.002} in the moderate RD group, and 4.09 (95% CI 1.48-11.28, p=0.006) in the severe RD 
group as compared to the normal RF group. Conclusion: Decreased admission eGFR was associated with worse clinical 
courses and it was an independent predictor of in-hospital mortality in STEMI patients undergoing primary PCI. (Korean 
Circ J 2011;41:184-190)
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Introduction
Renal dysfunction is a strong risk factor for cardiovascular 
disease in the general population,
1) and it is associated with 
an increased risk of death and cardiovascular events in pa-
tients with a broad range of cardiovascular diseases, includ-
ing heart failure,
2) stable coronary artery disease undergoing 
percutaneous coronary intervention (PCI)
3)4) and acute cor-
onary syndromes.
5)6) 
In the setting of acute myocardial infarction (AMI), mor-
tality risk is increased in patients with renal dysfunction (RD) 
of any degree of severity.
7-9) Primary PCI is the best reperfu-
sion strategy for AMI patients and its mortality benefit has 
been shown in randomized trials.
10-12) However, most of these 
trials frequently excluded patients with RD, and few studies 
examining the outcomes of AMI patients with RD undergo-
ing primary PCI have been reported.
To date, several studies evaluating the in-hospital prognos-
tic significance of RD in patients undergoing primary PCI for 
AMI have reported that RD is an independent predictor of in-
hospital mortality,
13-15) even in the case of a successful PCI.
13)14) 
However, one of these studies
13) used serum creatinine level 
to determine RD despite the fact that serum creatinine level 
can be unreliable as an estimate of renal function (RF), while 
the other studies
14)15) included a small number of patients and 
divided patients according to their RF into merely 2 groups 
which is insufficient for RD risk stratification. The aim of the 
present study was to investigate the impact of admission esti-
mated glomerular filtration rate (GFR) on in-hospital out-
comes in patients with ST-segment elevation myocardial in-
farction (STEMI) undergoing primary PCI using data from 
the Korea Acute Myocardial Infarction Registry (KAMIR).
Subjects and Methods
Korea Acute Myocardial Infarction Registry
KAMIR is a Korean prospective multicenter online regis-
try designed to reflect “real-world” practice trends for patients 
presenting with AMI in the recent reperfusion era; the regis-
try has been supported by the Korean Circulation Society 
since November 2005. Online registry of AMI cases (www.
kamir.or.kr) has been performed at 41 universities or com-
munity hospitals that are high-volume centers with facilities 
for primary PCI and onsite cardiac surgery. Data were col-
lected at each site by a trained study coordinator using a stan-
dardized case report form, and registered and submitted from 
individual institutions via password-protected internet-based 
electronic case report forms. The study protocol was approved 
by the ethics committee at each participating institution. 
Study population
From January 2006 to December 2007, a total of 7,895 ST-
EMI patients were registered in KAMIR. Of these, 864 pa-
tients were excluded from this study because they had re-
ceived fibrinolytic therapy and 2,407 patients were excluded 
because they did not undergo PCI as the primary treatment 
strategy; an additional 82 patients were excluded due to miss-
ing data needed to calculate estimated GFR. The remaining 
4,542 patients were eligible for the present study (Fig. 1). Data 
on clinical, angiographic and in-hospital outcomes were col-
lected. 
The mean age of the study patients was 62.2±12.8 years, 
and 3,355 (73.8%) patients were males. The mean estimated 
GFR was 78.3 mL/min/1.73 m
2. The angiographic success rate 
was 91.8%, and the overall in-hospital mortality rate was 5.3%.
Definitions
STEMI was defined by the presence of new ST-segment el-
evation of at least 1 mm (0.1 mV) in 2 contiguous leads or new 
left bundle-branch block on the index or subsequent electro-
cardiogram with at least 1 positive cardiac biochemical mark-
er of necrosis. Presence of left main coronary artery stenosis 
was defined as a luminal stenosis ≥50%. Primary PCI was 
defined as percutaneous coronary revascularization within 24 
hours of symptom onset without antecedent treatment with 
a fibrinolytic agent as the initial therapy. Successful PCI was 
defined as thrombolysis in myocardial infarction 3 flow with 
residual stenosis ≤50% in the infarct-related artery. Major ble-
eding was defined as intracranial bleeding, bleeding associ-
ated with the need for blood transfusion, or any other clini-
cally relevant bleeding as judged by the investigator.
Assessment of renal function
RF was defined by estimated GFR, which was calculated by 
Excluding patients
who received fibrinolysis (n=864)
Excluding patients
who underwent PCI not by primary strategy (n=2,407)
Excluding missing value
including age and creatinine (n=82)
KAMIR (January 2006 to December 2007)
STEMI on final diagnosis (n=7,895)
STEMI patients who underwent PCI (n=7,031)
STEMI patients who underwent primary PCI
within 24 hours of symptom onset (n=4,624)
Eligible patients (n=4,542)
Fig. 1. Study flow chart. STEMI: ST-segment elevation myocardi-
al infarction, KAMIR: Korea Acute Myocardial Infarction Registry, 
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the Modification of Diet in Renal Disease equation (MDRD)
16) 
from the serum creatinine level measured on admission. The 
patients were classified into 3 groups according to the estimat-
ed GFR. Normal RF, moderate and severe RD were defined as 
estimated GFR ≥60 mL/min/1.73 m
2, between 30 to 59 mL/ 
min/1.73 m
2 and <30 mL/min/1.73 m
2, respectively. 
Statistical analysis
All analyses were performed using Statistical Package for 
the Social Sciences (SPSS) software version 17.0 (SPSS Inc, 
Chicago, IL, USA). Data are presented as mean±standard 
deviation or median with interquartiles for continuous variables, 
and as frequency for categorical variables. Comparisons be-
tween continuous variables were done using one-way analysis 
of variance or the Kruskal-Wallis test, while the Pearson’s chi-
square test was used for categorical variables. Logistic regress-
ion analyses were performed to determine predictors of in-hos-
pital mortality. A probability value of p<0.05 was considered 
significant.
Table 1. Baseline clinical characteristics
Estimated GFR
p ≥60 mL/min/1.73 m
2
(n=3,515)
30-60 mL/min/1.73 m
2
(n=894)
<30 mL/min/1.73 m
2
(n=133)
Demographic characteristics
Age (years) 059.9±12.4 070.1±10.3 069.6±12.7 <0.001
Male gender (%) 79.0 56.8 52.6 <0.001
BMI (kg/m
2) 24.1±3.1 23.7±3.1 23.5±3.5  0.005
Admission characteristics
SBP (mmHg) 127.4±28.7 114.8±34.7 109.7±33.5 <0.001
HR (beats/min) 075.7±18.7 073.3±24.7 076.9±27.5  0.005
Killip class (%) <0.001
1 77.6 61.0 60.5
2 13.0 15.6 08.5
3 04.9 09.4 10.1
4 04.4 14.0 20.9
Killip class ≥3 (%) 09.3 23.4 31.0 <0.001
Symptom-to-door time (minutes)* 150 (72-287) 170 (73-309) 112 (46-223)  0.102
Door-to-balloon time (minutes)* 085 (60-127) 091 (64-136) 110 (69-138)  0.038
Medical history (%)
Hypertension 40.1 61.4 67.4 <0.001
Diabetes 20.3 32.7 42.1 <0.001
Hyperlipidemia† 18.6 16.6 16.9  0.373
Current smoking 53.5 30.2 32.6 <0.001
Family history of heart disease 07.8 04.0 00.8 <0.001
Previous MI 27.9 25.6 32.0  0.773
Previous CABG 03.1 04.0 04.0  0.883
Congestive heart failure 00.4 02.0 01.5 <0.001
Creatinine (mg/dL) 00.93±0.18 01.37±0.26 05.60±6.57 <0.001
GFR (mL/min/1.73 m
2) 087.9±41.3 49.6±7.9 17.5±9.1 <0.001
Peak CK-MB (IU/L)* 198 (73-300) 144 (33-273) 159 (51-251) <0.001
hs-CRP (mg/L)* 0.53 (0.14-1.95) 0.50 (0.12-1.98) 1.23 (0.12-5.49) <0.001
BNP (pg/mL)* 58 (18-204)0 128 (30-494) 211 (51-797) <0.001
LV ejection fraction (%) 051.2±11.3 048.7±12.6 048.4±12.9 <0.001
Heparin‡ 58.5 14.1 02.3  0.042
GP IIb/IIIa inhibitor 21.6 05.8 00.8  0.745
*Data are presented as the median with 25-75 percentiles, †Hyperlipidemia was defined as total cholesterol ≥220 mg/dL, ‡Heparin means low-
molecular weight heparin or unfractionated heparin. GFR: glomerular filtration rate, BMI: body mass index, SBP: systolic blood pressure, HR: 
heart rate, PCI: percutaneous coronary intervention, MI: myocardial infarction, CABG: coronary artery bypass graft surgery, CK-MB: creatine 
kinase MB fraction, BNP: B-type natriuretic peptide, hs-CRP: high sensitivity C-reactive protein, GP: glycoprotein Joon Young Kim, et al.   187
Results
Baseline clinical characteristics
A total 1,027 (22.6%) patients had at least moderate RD. Pa-
tients with RD were older, were more often females and had 
lower BMI values. Also, they were more likely to have lower 
systolic blood pressure, increased heart rate and higher Killip 
class at presentation. Pre-hospital delay time was similar in 
the RD group and the normal RF group, but door-to-balloon 
time was longer in the RD group as compared to the normal 
RF group. On medical history, they were more likely to have 
hypertension, diabetes and congestive heart failure. With re-
spect to laboratory findings, high sensitivity C-reactive pro-
tein and B-type natriuretic peptide levels were higher in the 
RD group, but peak creatine kinase-MB level and left ventric-
ular ejection fraction were lower in the RD group as com-
pared to the normal RF group. Use of both heparin and GP 
IIb/IIIa inhibitor was lower in the RD group as compared to 
the normal RF group (Table 1).
Angiographic and procedural characteristics
Patients with RD were more likely to have multivessel dis-
ease and left main coronary artery stenosis. The location of 
infarct-related artery was significantly different in the three 
groups, according to their RF. While involvement of the left 
anterior descending coronary artery was less frequent, invol-
vement of the right coronary artery was more frequent in the 
severe RD group. Also, rate of successful PCI decreased sig-
nificantly as RF declined; however, rate of stent insertion re-
mained similar in all the three groups (Table 2).
Table 2. Angiographic and procedural characteristics
Estimated GFR
p ≥60 mL/min/1.73 m
2
(n=3,515)
30-60 mL/min/1.73 m
2
(n=894)
<30 mL/min/1.73 m
2
(n=133)
No. of diseased vessels (%) <0.001
1 51.8 37.0 31.8
2 30.0 34.8 35.6
3 18.2 28.2 32.6
Presence of LM stenosis (%) 01.4 03.3 04.5 <0.001
Location of infarct-related artery (%) <0.001
LM 03.8 03.9 04.1
LAD 17.3 16.5 12.3
LCX 26.6 25.0 18.9
RCA 52.2 54.6 64.8
Type of lesion (%)  0.408
A/B1 16.4 04.0 00.5
B2/C 61.1 15.7 02.4
Rate of successful PCI (%) 93.1 87.7 87.2 <0.001
Rate of stent use (%) 94.3 93.0 93.0  0.315
LM: left main, LAD: left anterior descending, LCX: left circumflex, RCA: right coronary artery
Table 3. Incidence of in-hospital complications
Estimated GFR
p ≥60 mL/min/1.73 m
2
(n=3,515)
30-60 mL/min/1.73 m
2
(n=894)
<30 mL/min/1.73 m
2
(n=133)
Complications (%) 14.1 31.8 45.5 <0.001
AV block 02.6 07.0 08.3 <0.001
VT/VF 03.4 05.8 06.0 0.002
Atrial fibrillation 01.1 02.1 04.5 0.001
Cardiogenic shock 04.3 14.1 19.5 <0.001
Ischemic event* 00.9 02.0 03.0 0.005
Acute renal failure† 00.1 01.8 06.0 <0.001
Major bleeding 00.3 01.9 04.8 <0.001
*Ischemic event includes recurrent ischemia, re-infarction and cerebrovascular event, †Acute renal failure requiring renal replacement thera-
py. AV block: atrioventricular block, VT: ventricular tachycardia, VF: ventricular fibrillation 188   Estimated GFR as a Predictor in AMI Patients Undergoing Primary PCI
Clinical outcomes
In-hospital complications, including arrhythmia, cardioge-
nic shock, ischemic events, acute renal failure and major ble-
eding, developed more frequently in patients with RD (Table 
3). In-hospital mortality rates increased significantly as esti-
mated GFR decreased (p<0.001), and approximately one-four-
th of the patients (25.6%) in the severe RD group died (Fig. 2). 
Although the main cause of in-hospital mortality was pump 
failure (p<0.001), frequencies of the causes of mortality were 
not significantly different between the three groups (p=0.165) 
(Table 4). On multivariate logistic regression analysis, age, 
diabetes, Killip class ≥3, successful PCI and left ventricular 
ejection fraction were identified as independent predictors of 
in-hospital mortality. In addition, decreased estimated GFR 
was also identified as a powerful independent predictor of in-
hospital mortality. When compared with the normal RF group, 
adjusted OR was 2.67 {95% confidence interval (CI): 1.44 to 
4.93; p=0.002} in the moderate RD group and 4.09 (95% CI: 
1.48 to 11.28; p=0.006) in the severe RD group (Table 5).
Discussion
The main finding of the present study is that RD defined by 
estimated GFR at admission is an independent predictor of in-
hospital mortality in patients with STEMI undergoing pri-
mary PCI; this increased mortality risk was observed not only 
in the patients with severe RD but also in the patients with mo-
derate RD.
In the present study, RD was defined by estimated GFR cal-
culated using the MDRD equation, which is currently recom-
mended in clinical practice,
17) and patients were divided into 
three groups. Although RD, as defined by either serum creati-
nine level or estimated GFR, has been associated with in-
creased mortality in patients with AMI,
13-15)18)19)21) serum cre-
atinine level is insensitive for an early detection of RD and 
could underestimate the incidence of moderate or severe RD 
concealed behind the near-normal creatinine levels,
9)22)23) th-
ereby underscoring the risk of RD in AMI patients. Further-
more, a graded risk of RD clearly exists, RF should be classifi-
ed into at least 3 groups using estimated GFR for appropriate 
RD risk stratification in clinical practice. Our study on the 
basis of estimated GFR, showed that patients with moderate 
RD had a six-fold higher in-hospital mortality rate, while 
Table 4. Causes of in-hospital mortality
Estimated GFR
p ≥60 mL/min/1.73 m
2
(n=3,515)
30-60 mL/min/1.73 m
2
(n=894)
<30 mL/min/1.73 m
2
(n=133)
Cause of hospital mortality (%) 0.165
Pump failure 52.4 71.3 67.6
Mechanical complications 07.3 04.1 08.8
Arrhythmia 12.2 09.0 11.8
Multi-organ failure 11.0 09.0 11.8
Bleeding 01.8 01.6 02.4
GFR: glomerular filtration rate
Table 5. Multivariate logistic regression analysis of predictors of in-
hospital mortality
Adjusted OR 95% CI p
Estimated GFR 
  (mL/min/1.73 m
2)
≥60 1.00
30-60 2.67 1.44-4.93  0.002
<30 4.09 1.48-11.28  0.006
Age (per year) 1.06 1.03-1.09 <0.001
Killip class ≥3 2.85 1.58-5.14 <0.001
LV ejection fraction 0.91 0.89-0.93 <0.001
Successful PCI 0.39 0.19-0.81  0.011
Diabetes  2.08 1.15-3.74  0.015
Presence of left main 
  artery stenosis  2.74 0.86-8.75  0.090
Stent use 0.60 0.22-1.61  0.310
Male gender 0.73 0.39-1.36  0.318
Hypertension 1.27 0.70-2.30  0.427
Multivessel disease 0.76 0.38-1.53  0.449
Body mass index 1.02 0.94-1.11  0.650
OR: odds ratio, CI: confidence interval, GFR: glomerular filtration 
rate, LV: left ventricle, PCI: percutaneous coronary intervention
Fig. 2. Incidence of in-hospital mortality according to the levels of 
estimated glomerular filtration rate.
30
25
20
15
10
5
0
2.3
13.9
p<0.001
25.6
≥60 mL/min/
1.73 m2 (n=3,515)
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1.73 m2 (n=133)
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1.73 m2 (n=894)
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patients with severe RD had a eleven-fold higher in-hospital 
mortality rate as compared to the patients with normal RF. In 
our study, patients with RD were older, and were more often 
women. Although RF decreases with age and women tend to 
be older than men at the time of AMI presentation,
24) it may 
also be an inherent influence of the variables used in the MD-
RD equation. In addition to older age and female gender, RD 
was more frequently associated with hypertension, diabetes, 
higher Killip class, multivessel disease and low left ventricu-
lar ejection fraction. These findings which have been describ-
ed by other authors
13)19)21) predispose to worse clinical out-
comes after AMI. However, after adjustment for baseline dif-
ferences, increased in-hospital mortality persisted in the pa-
tients with RD, suggesting that an increased mortality in 
patients with RD was not fully explained by these associated 
conditions, and that RD is a strong independent predictor of 
in-hospital mortality.
The rate of in-hospital complications was higher in the pa-
tients with RD as compared to the patients with normal RF. 
Cardiogenic shock, the most common cause of death in this 
study regardless of RF, developed with a three-fold higher 
frequency. It may be possible that the high incidence of un-
successful PCI, recurrent ischemia or re-infarction and bleed-
ing may potentiate the already existing weakened ischemic 
resistance reflected by high prevalence of diabetes and multi-
vessel disease in the RD group. Also, acute renal failure devel-
oped more frequently in the RD group. After AMI, acute re-
nal failure more commonly developed among those patients 
with low left ventricular ejection fraction, higher Killip class, 
anterior wall infarction, a hematocrit <30%, congestive heart 
failure, cardiogenic shock or stroke during admission.
25) The 
RD group in our study shared many of these features, and al-
though this study did not assess contrast-induced nephropa-
thy (CIN) it may also contribute to it. Usually, the clinical be-
nefit of primary PCI is accompanied by an increased risk of 
bleeding in AMI patients with RD, and a previous study has 
reported that RD is independently associated with bleeding 
after primary PCI.
19) As expected, despite the less frequent 
use of heparin and glycoprotein IIb/IIIa inhibitors in the RD 
group as compared to the normal RF group, which have a pro-
ven efficacy in the setting of AMI, major bleeding increased 
significantly in the RD group as compared to the normal RF 
group.
Despite the fact that primary PCI is the most effective AMI 
treatment in terms of improvement in survival, this mortality 
benefit is attenuated in some patient subgroups, including the 
elderly, women, patients with renal insufficiency, heart failure, 
diabetes, anaemia, acute hyperglycemia, cardiogenic shock, 
and those developing CIN.
15) Because the patients with RD 
frequently have more than one of these conditions, they might 
be at a very high risk of mortality after AMI. Therefore, man-
agement of AMI in patients with RD is particularly problema-
tic. A recent study by Medi et al.
26) which investigated the be-
nefit of reperfusion strategies in STEMI patients in the 
presence of RD, reported that mortality rates remain high; 
they also found that primary PCI was associated with a low-
er adjusted in-hospital mortality than fibrinolytic therapy in 
the patients with normal RF and moderate RD. However, in 
the patients with severe RD, primary PCI was not associated 
with reduced mortality. In conclusion, we have limited know-
ledge on the optimal reperfusion strategy for the severe RD 
group.
To improve the survival in AMI patients with RD undergo-
ing primary PCI, more aggressive treatment and meticulous 
care are needed. Firstly, the success of primary PCI has spe-
cial importance because a successful PCI is an independent 
predictor of in-hospital mortality as shown in our study and 
RD was shown to be associated with the risk of unsuccessful 
PCI results. Secondly, medications such as aspirin, beta-bl-
ockers, and ACE inhibitors should be administered early af-
ter AMI, so that the patients with RD could gain a similar mor-
tality benefit as their normal RF counterparts.
27)28) Thirdly, 
reducing bleeding complications
29) by using the radial artery 
approach and direct thrombin inhibitor during PCI is need-
ed.
30) Fourthly, an effort should be made to prevent CIN, in-
cluding adequate hydration, reducing contrast use, use of low-
osmolarity contrast and administration of N-acetylcysteine.
19)20) 
Because KAMIR is a large multicenter population-based 
prospectively-designed study including unselected patients 
with AMI, it provides comprehensive information on treat-
ments and outcomes among patients with AMI and RD in the 
contemporary PCI era. Because this study included STEMI 
patients only, the median pre-hospital delay time in the RD 
group was relatively short as compared to that in the previous 
studies
13)19); this feature could minimize the hemodynamic 
compromising effect of AMI on baseline serum creatinine 
level.
Limitations 
The present study had several limitations. Firstly, we in-
cluded only those individuals who underwent primary PCI. 
Similar to a previous study, because the patients with RD un-
derwent PCI less often as compared to those with normal RF, 
there might be a selection bias and unidentified confound-
ers, which might limit the generalizability of the data. Second-
ly, we did not collect information on medications relevant 
for prognostication, and therefore analyses in this study was 
not controlled for the impact of these drugs. Thirdly, there are 
inherent limitations of the estimated GFR calculation.
17) 
Conclusions 
Decreased estimated GFR on admission is a strong risk fac-
tor for increased in-hospital complications and mortality in ST-
EMI patients undergoing primary PCI. These risks increased 190   Estimated GFR as a Predictor in AMI Patients Undergoing Primary PCI
in a stepwise fashion according to the degree of decreased 
estimated GFR. Clinicians should be alert to the increased 
mortality in patients with RD and make all the attempts to re-
duce complications of primary PCI and stress intensive medi-
cal management of these high-risk patients. 
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